Peter LeWitt
Henry Ford Health System · Henry Ford Hospital - West Bloomfield
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Peter LeWitt as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:55 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06312800 · Acamprosate and Methazolamide for Essential TremorHenry Ford Health System · withdrawn · Essential Tremor · principal investigator
- Ph3NCT02615873 · A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004Intec Pharma Ltd. · unknown · Parkinson's Disease · principal investigator
- Ph2NCT02066571 · Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's DiseaseHenry Ford Health System · unknown · Parkinson's Disease, Freezing of Gait, Cognitive Ability, General · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:55 UTC. The ranking covers the 200 most relevant of 68 PubMed records, and a shared surname and initials can bring in a namesake. All 68 on PubMed
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.Lancet Neurol · 2011467 citationsRCR 12.9
- Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.Arch Neurol · 2004432 citationsRCR 12.6
- 285 citationsRCR 8.5
- 281 citationsRCR 8.1
- 207 citationsRCR 5.8
- Advanced Parkinson disease treated with rotigotine transdermal system: PREFER Study.Neurology · 2007196 citationsRCR 6.5
- A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for parkinsonian off-state events.Arch Neurol · 2001181 citationsRCR 5.7
- 176 citationsRCR 6.2
- 152 citationsRCR 10.7
- Clinician versus machine: reliability and responsiveness of motor endpoints in Parkinson's disease.Parkinsonism Relat Disord · 2014130 citationsRCR 6.1